PPARG and breast carcinoma: The activation of PPARG has been increasingly shown to inhibit the proliferation, migration and invasion of breast cancer cells, while its down-regulation promotes the progression of cachexia in breast cancer patients (Janani and Ranjitha-Kumari, 2015; Yang et al., 2020; Kandel et al., 2021).